Skip to main content

Table 1 Demographic and preoperative data in patients receiving dexmedetomidine-ketamine or dexmedetomidine-midazolam-fentanyl

From: Dexmedetomidine-ketamine versus Dexmedetomidine-midazolam-fentanyl for monitored anesthesia care during chemoport insertion: a Prospective Randomized Study

 

Group DK (n = 25)

Group DMF (n = 27)

Age (yrs)

50.6 ± 9.8

46.7 ± 6.2

Sex (M/F)

3/22

1/26

Height (cm)

159.2 ± 6.2

159.3 ± 6.3

Weight (kg)

58.8 ± 9.1

59.3 ± 7.0

ASA physical status(I/II)

20/5

21/6

MBP (mmHg)

89 ± 14

92 ± 18

HR (beats/min)

75 ± 15

74 ± 9

SpO2 (%)

100 ± 0.0

100 ± 0.3

Respiratory Rate

19.6 ± 0.8

19.5 ± 0.9

  1. Data are presented as number or mean ± SD. There are no significant differences between the two groups
  2. ASA American Society of Anesthesiologists, group DK dexmedetomidine-ketamine group, group DMF dexmedetomidine-midazolam-fentanyl group, MBP mean blood pressure, HR heart rate, SpO 2 hemoglobin oxygen saturation by pulse oximeter
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us